Medicure is a specialty pharmaceutical company established in 1997. The Company's vision is to become a leading specialty pharmaceutical company in the commercialization and development of unique small molecule pharmaceuticals in the cardiovascular and neurological fields for unmet medical needs.

GVI Clinical Development Solutions (CDS) is an innovative contract research organization that provides hands-on clinical and regulatory support to biotechnology, pharmaceutical, diagnostic, nutraceutical and medical device companies.

CanAm Bioresearch is a well-established pharmaceutical contract research organization specializing in pre-clinical discovery and development. The company provides bioanalytical, pharmacokinetic, pharmacology, and custom chemical synthesis services.

KAM Scientific is the manufacturer and distributor of Virocidin-X, a potent, ready-to-use microbial disinfectant spray solution. KAM Scientific's primary focus is the marketing and distribution of novel scientific products for commercial use.

Kane Biotech Inc. is a publicly traded biotechnology company established around a patent protected technology to find compounds which prevent or disrupt biofilms in medical and industrial applications. The Company has three technology platforms and Kane Biotech's two lead market areas are medical device coatings and wound care products.

Diamedica Inc. is a biopharmaceutical company focused on developing unique pharmacologic therapies for type 2 diabetes. DM-71, the Company's most clinically advanced product, may be able to reduce blood sugar and weight in people diagnosed with type 2 diabetes, as shown in an early phase IIa clinical trial.

Sanomune is a product focused biopharmaceutical company oriented towards therapeutic regulation of the immune system. The company has identified a naturally-occurring protein with applications as a therapy for Alzheimer's, Autoimmune diseases and several additional indications.